Association of IGF1R polymorphisms with kidney function-related traits.

Genes Genomics

Department of Biomedical Laboratory Science, College of Life and Health Sciences, Hoseo University, 20 Hoseo-Ro 79 Beon-Gil, Asan-Si, Chungcheongnam-Do, 31499, Republic of Korea.

Published: December 2023

Background: Unimpaired kidney function is important for maintaining a healthy state of homeostasis in the body. A genome-wide association study (GWAS) conducted on kidney function-associated traits and novel loci of Japanese subjects found that insulin-like-growth factor 1 receptor (IGF1R) gene variants associated with replication were responsible for all three kinds of kidney functions and satisfied the Bonferroni significance level.

Objective: This study aimed to investigate whether a comparable relationship exists in the Korean population.

Method: This study replicated three SNPs (rs28657002, rs10794486, and rs4966025) and conducted a linear regression analysis between 46 SNPs in the IGF1R gene and three kidney function-related traits, namely blood urea nitrogen (BUN), creatinine, and estimated glomerular filtration rate (eGFR) in Koreans.

Results: The IGF1R gene was found to be replicated with a significant correlation in Koreans and was extended to the entire gene region to confirm its association with kidney-related functions. Three SNPs in IGF1R were replicated (rs28657002, BUN, P = 3.39 × 10; rs10794486, creatinine, P = 5.79 × 10; rs4966025, eGFR, P = 1.57 × 10) and five SNPs (rs28657002, rs10794486, rs4966025, rs12439557, and rs11247372) showed common significance among the three traits. Additionally, two significant SNPs (rs11857366 and rs28657002) showed the potential to affect IGF1R expression.

Conclusions: The results suggest that genetic polymorphisms in the IGF1R replicated previous studies and could affect kidney function. The results of this study will further enhance our understanding of how genetic differences in individuals affect kidney function-related traits.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13258-023-01430-5DOI Listing

Publication Analysis

Top Keywords

kidney function-related
12
function-related traits
12
igf1r gene
12
kidney function
8
three snps
8
snps rs28657002
8
rs28657002 rs10794486
8
rs10794486 rs4966025
8
snps igf1r
8
igf1r replicated
8

Similar Publications

Ethnopharmacological Relevance: Rostellularia procumbens (L) Nees. (R. procumbens) is a classical Chinese herbal medicine that has been used for effective treatment of kidney disease for nearly a thousand years in China.

View Article and Find Full Text PDF

Reactivation of mTOR signaling slows neurodegeneration in a lysosomal sphingolipid storage disease.

Neurobiol Dis

January 2025

Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address:

Sandhoff disease, a lysosomal storage disorder, is caused by pathogenic variants in the HEXB gene, resulting in the loss of β-hexosaminidase activity and accumulation of sphingolipids including GM2 ganglioside. This accumulation occurs primarily in neurons, and leads to progressive neurodegeneration through a largely unknown process. Lysosomal storage diseases often exhibit dysfunctional mTOR signaling, a pathway crucial for proper neuronal development and function.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the impact of adding Guanxinning to standard treatments for stable coronary artery disease (SCAD) patients, who still face high cardiovascular risks despite being on medications like statins.
  • After a 12-week trial with 50 SCAD patients, those taking Guanxinning showed significant reductions in several inflammation markers and improvements in endothelial function and blood lipid profiles compared to the control group.
  • However, there was no notable difference in levels of IL-4, triglycerides, or other health indicators like liver and kidney function between the two groups, suggesting that while Guanxinning may help reduce inflammation, not all health metrics are significantly impacted.
View Article and Find Full Text PDF

GLIS3: A novel transcriptional regulator of mitochondrial functions and metabolic reprogramming in postnatal kidney and polycystic kidney disease.

Mol Metab

December 2024

Cell Biology Group, Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, 27709, USA. Electronic address:

Objectives: Deficiency in the transcription factor (TF) GLI-Similar 3 (GLIS3) in humans and mice leads to the development of polycystic kidney disease (PKD). In this study, we investigate the role of GLIS3 in the regulation of energy metabolism and mitochondrial functions in relation to its role in normal kidney and metabolic reprogramming in PKD pathogenesis.

Methods: Transcriptomics, cistromics, and metabolomics were used to obtain insights into the role of GLIS3 in the regulation of energy homeostasis and mitochondrial metabolism in normal kidney and PKD pathogenesis using GLIS3-deficient mice.

View Article and Find Full Text PDF
Article Synopsis
  • - Fenpropathrin (FPT), a synthetic insecticide, poses risks to aquatic life by increasing oxidative stress and affecting the immune systems of fish like Cyprinus carpio through lipid peroxidation and iron metabolism disruption.
  • - Results revealed that exposure to FPT leads to lymphocyte death, ferroptosis, imbalances in iron transport, and increases in inflammatory gene expression, indicating significant immunotoxic effects.
  • - Treatment with the ROS inhibitor NAC showed potential for mitigating FPT-induced damage by reducing ferroptosis and inflammation, highlighting a pathway for protecting aquatic health from FPT exposure.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!